Received Feb 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Circumstances or information capable of leading to medication error; This non-serious case was reported by a other health professional and described the occurrence of circumstance or information capable of leading to medication error in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced circumstance or information capable of leading to medication error (Verbatim: Circumstances or information capable of leading to medication error). The outcome of the circumstance or information capable of leading to medication error was not applicable. Additional Information: GSK Receipt Date:13-FEB-2026 The other healthcare professional wanted to highlight a potentially dangerous situation, as the new packaging for Shingrix looked nearly identical to the packaging of Havrix 720 EL.U. and had requested to review this and consider changing the colors on the Shingrix packaging. The batch number was not provided and the request for the information has been made.